Session 23: Medicine: Evidence-Based Research: Plenary Session

Abstract: This session will present new evidence-based data from recently performed clinical trails to be chosen before the meeting.

(23.1) Antimicrobial sensitivity of chronic wounds

(23.2) The economic advantages of a once-daily parenteral antibiotic: a cost analysis of the SIDESTEP study

(23.3) Nitric oxide donors reduce MMP expression in diabetic skin wound fibroblasts

(23.4) Talactoferrin gel may promote healing of diabetic neuropathic ulcers

(23.5) Perioperative pressure ulcer assessment and prevention efficacy study of a multilayered pad for the operating room (OR)

Session 32: Oral Abstracts (Session 1 of 5)

(32.1) The challenge of healing wounds in the noncompliant patient: a case study

(32.2) An algorithm for the management of lower-extremity diabetic wounds using an acellular regenerative matrix based on UT wound classification

(32.3) Pregabalin for the treatment of painful diabetic neuropathy of the foot and ankle and possible prevention of neuropathic ulceration

(32.4) A solution to the worse case scenario: successful treatment of class IIID diabetic foot ulcers using an acellular regenerative tissue matrix

(32.5) Healing of a 2-year-old traumatic ankle ulcer in an elderly woman with diabetes using an acellular regenerative tissue matrix

Session 33: Oral Abstracts (Session 2 of 5)

(33.1) A synthesis of level-one evidence from Cochrane systematic reviews on local wound care

(33.2) Evaluation of pain control and healing rates using an advanced cellulose dressing with 0.3% polyhexamethylene biguanide (PHMB)*

(33.3) Case study of a unique enzyme moisturizer* to combat post-burn pruritus

(33.4) Treatment of painful skin ulcers with a biocellulose dressing containing lidocaine

(33.5) Wounds measured from digital photographs using photo-digital planimetry software: validation and rater reliability

Session 34: Oral Abstracts (Session 3 of 5)

(34.1) Lactoferrin promotes human skin keratinocyte proliferation

(34.2) Characterization of the local wound environment following treatment of chronic leg ulcers with SIS wound matrix

(34.3) Noninvasive electric magnetic fields: effects on keratinocyte migration and proliferation

(34.4) Randomized clinical trial comparing modern versus gauze dressings to treat open wounds in surgical patients

(34.5) Assessment of local tissue edema in arms of women with postmastectomy lymphedema

Session 35: Oral Abstracts (Session 4 of 5)

(35.1) Results of a phase I, randomized, double-blind, placebo-controlled trial of topical rhVEGF (telbermin) for the treatment of diabetic foot ulcers

(35.2) The use of an acellular dermal regenerative tissue matrix in the treatment of diabetic foot ulcers: a 17-week analysis

(35.3) Incidence of mycobacterium infections related to nail salons

(35.4) Verrucous carcinoma in traumatic spinal cord injury

(35.5) Closing the gap: process model of healing in persons living with chronic skin wounds

Session 36: Oral Abstracts (Session 5 of 5)

(36.1) Skin care protocols for pressure ulcers and incontinence in long-term care: a quasi-experimental study

(36.2) Subepidermal moisture measures and visual skin assessment of erythema and pressure ulcers

(36.3) Use of polyurethane foam dressings in debrided diabetic wounds

(36.4) Does your protocol prevent heel ulcers?

(36.5) Using L-arginine to reduce pain and heal ulcers in patients with nonreconstructable vascular disease